CSN Chesnara plc

Chesnara PLC (LSE:CSN) saw operating capital generation jump 79% to £96 million in the first half. CEO Steve Murray also highlighted the group's 185% solvency coverage ratio and an active acquisition pipeline. Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) has raised £1.3 million to push forward its CNS drug pipeline. That includes trials for alcohol use disorder and addiction treatments. hVIVO PLC (AIM:HVO) has bought CRS Berlin to expand into dermatology and women's health trials. The CEO says it opens up new markets and cross-selling opportunities in Germany. Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) has completed drone battery testing with QinetiQ on its sulfur cathode material. Cells showed barely any degradation even after 50 aggressive test cycles. Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF, FRA:TMU) is expecting a strong flow of assay results over the coming weeks at Mushima North. Those results should feed into a maiden resource estimate by year-end. Iofina PLC (AIM:IOF, OTC:IOFNF) is ramping up iodine production at its IO#11 plant with a new brine source. Its next plant, IO#12, should be online before the end of the quarter. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.

Chesnara PLC (LSE:CSN) CEO Steve Murray spoke with Proactive about first-half performance, including a 79% rise in operating capital generation to £96 million, progress integrating Chesnara Life and the outlook for further acquisitions. Murray said the strong capital generation reflected positive underlying performance, management actions like balance-sheet optimisation and reinsurance, and a significant contribution from Chesnara Life, formerly HSBC Life UK, which joined the group at the end of January. On integration, Murray said Chesnara has announced a combined UK leadership team and begun transferring relevant staff to strategic outsourcing partner SS&C, remaining on track to migrate HSBC data onto the SS&C platform by year-end. He also discussed the planned acquisition of Scottish Widows Europe, expected to add around €250 million of lifetime cash generation — roughly €100 million within the first five years — while establishing a Luxembourg platform Chesnara sees as a springboard for further consolidation. Turning to M&A more broadly, Murray highlighted the group's 185% solvency coverage ratio and an active acquisition pipeline: "That gives us a lot of flexibility in terms of our ability to go after acquisitions." The interview also covers the 152% rise in new business contribution to £12 million, driven by demand for UK onshore bonds, plus positive client cash flows in Sweden and demand for insurance and investment products in the Netherlands. Visit Proactive’s YouTube channel for more interviews and market updates. Don’t forget to give the video a like, subscribe to the channel and enable notifications for future content. Read Proactive's Editorial Policy here: https://www.proactiveinvestors.co.uk/pages/editorialPolicy #Chesnara #ChesnaraPLC #SteveMurray #Insurance #LifeInsurance #InsuranceSector #MergersAndAcquisitions #MandA #Acquisitions #ChesnaraLife #HSBCLife #ScottishWidows #ScottishWidowsEurope #CapitalGeneration #UKInvesting #InvestmentNews #InvestorNews #FinancialMarkets #ProactiveInvestors #Proactive

Chesnara (LON:CSN) reported higher operating capital generation, cash remittances and adjusted operating profit for the first half of 2026, supported by the January acquisition of HSBC Life UK, now renamed Chesnara Life UK. Group Chief Executive Steve Murray said the company delivered “another very

Chesnara PLC (LSE:CSN) is still hunting for acquisitions, with its Scottish Widows Europe deal on track by year end. Reporting back for the first half of its financial year, the company said operating capital generation jumped 79% to £96 million. Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) has raised £1.3 million to fund three separate treatment programmes. That includes trials targeting alcohol, and methamphetamine and cocaine use disorders. Savannah Energy PLC (AIM:SAVE) says its Uquo 13 well in Nigeria has started producing gas. It's now expecting output to top 20,000 barrels of oil equivalent per day. Eco (Atlantic) Oil & Gas Ltd (TSX-V:EOG, AIM:ECO) could have exposure to around 225 million barrels of oil at a Falklands drilling target. Partner Navitas is set to drill there as part of its Sea Lion campaign. Emmerson PLC (AIM:EML) has been given a July 2028 hearing date for its billion-dollar arbitration case against Morocco. It's all linked to the loss of its Khemisset potash project. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.